Pune, India, Aug. 24, 2022 (GLOBE NEWSWIRE) -- According to MarketStudyReport, that global plasma fractionation market is slated to expand at 6.4% CAGR through the review period and reach a valuation of USD 14 billion by the end of 2028.
Furthermore, the document segregates the market by product type, application spectrum, and end-user ambit, offering growth rate projections for each sub-division. The report assists decision-makers in understanding the market's growth potential by presenting revenue share figures for each vertical.
It also highlights the regions that are expanding the market’s earning potential. Furthermore, basic company profiles and expansion tactics of companies are studied in depth to furnish a thorough analysis of the competitive sphere.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5419138/
The development of the industry is backed by numerous parameters such as surging geriatric population who are predisposed to serious illnesses that necessitate the use of plasma extracts for treatment, combined with the increase in plasma collection centers around the world.
For the unaware, fractionation is the process of separating a specific amount of a particular element from a mixture. Plasma is a fluid component of blood that is fractionated to produce various plasma derivatives which have therapeutic properties and are used to treat a variety of blood plasma-related illnesses.
Besides, favorable government policies to spread awareness about the use of plasma-derived products are likely to accelerate industry development through 2028.
Despite the positive outlook, the huge costs of such products may impede the progress of the business landscape in the forthcoming years.
Segmental Overview:
In terms of product type, worldwide plasma fractionation market is split into albumins, coagulation factor concentrates, immunoglobulins, and others. Of these, the immunoglobulins segment recorded a significant market share in 2021 and is expected to maintain decent growth during the projected timeline, as the product is used for variety of disorders like inflammatory diseases, autoimmune ailments, and secondary immune deficiencies.
Based on application realm, the industry is divided into immunology, neurology, hematology, and others. Of these, the neurology vertical retained a substantial revenue share in 2021 and is estimated to register modest expansion during the stipulated period.
For end-user ambit, the business sphere is classified into research laboratories, hospitals & clinics, and others. Among these, the hospitals & clinics segment captured a considerable market share in 2021 and is likely to observe subtle development during the study period.
Ask Discount of this research report at @ https://www.marketstudyreport.com/check-for-discount/5419138/
Regional Analysis:
Seasoned analysts have asserted that the market trends span across numerous countries in the regions of Asia Pacific, Europe, and North America. From these, North America market held a colossal revenue share in 2021 and is poised to witness a considerable CAGR during the research timeframe.
Meanwhile, Asia Pacific industry is anticipated to showcase robust growth through 2028, on account of focus among government to regulate & supervise plasma collection, fractionation, and sales. Also, increasing cases of autoimmune disorders, booming geriatric populace, and enhancing healthcare infrastructure are creating lucrative opportunities for market growth in APAC.
Competitive Dashboard:
The established names in global plasma fractionation industry are Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Bio Products Laboratory (BPL) Ltd., Octapharma AG, Kedrion S.p.A, Biotest AG, Grifols International S.A., China Biologic Products Inc., and CSL Ltd. among others.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-plasma-fractionation-market-2022-2028
Global Plasma Fractionation Market, By Product Type (Revenue, USD Billion, 2018-2028)
- Immunoglobulins
- Albumins
- Coagulation Factor Concentrates
- Others
Global Plasma Fractionation Market, By Application (Revenue, USD Billion, 2018-2028)
- Neurology
- Immunology
- Hematology
- Others
Global Plasma Fractionation Market, By End-User (Revenue, USD Billion, 2018-2028)
- Hospitals and Clinics
- Research Laboratories
- Others
Global Plasma Fractionation Market, Regional Analysis (Revenue, USD Billion, 2018-2028)
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
Global Plasma Fractionation Market, Competitive Dashboard (Revenue, USD Billion, 2018-2028)
- Shanghai RAAS Blood Products Co. Ltd.
- Baxter International Inc.
- Bio Products Laboratory (BPL) Ltd.
- Octapharma AG
- Kedrion S.p.A
- Biotest AG
- Grifols International S.A.
- China Biologic Products Inc.
- CSL Ltd.
Table of Contents:
FIGURES AND TABLES
PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
- Immunoglobulins
- Albumins
- Coagulation factor concentrates
- Others
PART 6. MARKET BREAKDOWN BY APPLICATION
- Neurology
- Immunology
- Hematology
- Others
PART 7. MARKET BREAKDOWN BY END USER
- Hospitals and clinics
- Research laboratories
- Others
PART 8. MARKET BREAKDOWN BY REGION
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
PART 9. KEY COMPANIES
Related Report:
Global Plasma Therapy Market Size study and Regional Forecasts 2022-2028
Global Plasma Therapy Market to reach USD 653.3 million by 2028.Global Plasma Therapy Market is valued approximately USD 261.08 million in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2022-2028. Plasma is one of the components that are present in the blood, which carries essential nutrients, hormones, and proteins to the body parts that need it. The primary objective of plasma therapy is to transfer the immunity of a healthy individual to another patient. The plasma generally encompasses a large number of antibodies that aid in curing various diseases. The growing incidences of sports injuries, rising number of patients suffering from androgenic alopecia, arthritis, and orthopedic disorders, and increasing adoption of platelet-rich plasma in various therapeutic applications are the chief factors that accelerate the market growth across the globe.
About US:
Market Study Report is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.
